ethinyl estradiol has been researched along with Gigantism in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
| Heinze, E; Heinze, F; Scholler, K; Sorgo, W; Teller, WM | 1 |
| Kadlecová, I; Krejcová, M; Nováková, J; Straková, M | 1 |
| Hinkel, GK | 1 |
| Boomsma, DI; Fijnvandraat, K; Gevers Leuven, JA; Hennis, BC; Kluft, C; Peters, M | 1 |
| Klittich, L; Lehr, HJ; Schmidt-Elmendorff, H; Steyer, M | 1 |
| Blunck, W | 1 |
| Prader, A | 1 |
| Ehmke, H; Kaiser, R; Kloppenburg, W; Schwenk, H | 1 |
2 trial(s) available for ethinyl estradiol and Gigantism
| Article | Year |
|---|---|
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way.
Topics: Adolescent; Age Factors; Aged; Body Height; Child; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Gigantism; Humans; Medrogestone; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Proteins; Risk; Thromboembolism | 1995 |
8 other study(ies) available for ethinyl estradiol and Gigantism
| Article | Year |
|---|---|
Critical analysis of height reduction in oestrogen-treated tall girls.
Topics: Adolescent; Age Determination by Skeleton; Body Height; Child; Drug Therapy, Combination; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Gigantism; Humans; Lynestrenol | 1984 |
[Problems in the treatment of excessive growth in children using sex hormones].
Topics: Adolescent; Child; Ethinyl Estradiol; Female; Gigantism; Humans; Hydroxyprogesterones; Male; Progesterone Congeners | 1982 |
[Treatment of gigantic girls and boys].
Topics: Adolescent; Bone Development; Child; Ethinyl Estradiol; Female; Gigantism; Humans; Male; Sex Factors; Testosterone | 1980 |
[Estrogen treatment of excessively tall girls (author's transl)].
Topics: Adolescent; Age Factors; Body Height; Bone Development; Child; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Gigantism; Growth; Humans; Norethindrone; Puberty | 1978 |
[Therapeutic principles of constitutional accelerated growth].
Topics: Body Height; Child; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gigantism; Growth; Growth Disorders; Humans; Male; Mestranol; Time Factors | 1975 |
[Proceedings: Treatment of accelerated growth].
Topics: Adolescent; Child; Diethylstilbestrol; Estrogens; Ethinyl Estradiol; Female; Gigantism; Gonadotropins; Growth Disorders; Humans; Male | 1975 |
[The menstrual cycle after hormonal growth inhibition in girls].
Topics: Adolescent; Body Height; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Gigantism; Growth; Humans; Medrogestone; Menarche; Menstrual Cycle; Ovary; Pregnadienes; Time Factors | 1987 |
[Hormonal treatment of excessive height in girls].
Topics: Adolescent; Body Height; Bone Development; Child; Diethylstilbestrol; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gigantism; Humans | 1967 |